SEC Info - Adorbs Inc. - ‘10-12G/A’ on 11/18/20

SEC Info℠

Home

My Interests

Help

Please Sign In

Adorbs Inc. – ‘10-12G/A’ on 11/18/20 – ‘EX-99.26’

On: Wednesday, 11/18/20, at 2:34pm ET · Accession #: 1213900-20-37931 · File #: 0-56213

Previous ‘10-12G’: ‘10-12G’ on 10/7/20 · Next: ‘10-12G/A’ on 12/14/20 · Latest: ‘10-12G/A’ on 12/22/20 · 15 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/18/20  Adorbs Inc.                       10-12G/A               6:838K                                   EdgarAgents LLC/FA

Amendment to Registration Statement — Form 10 — Sect. 12(g) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-12G/A    Amendment No. 1 to Form 10-12G                      HTML    333K 
 2: EX-99.22    Demand Promissory Note Payable to Activist          HTML     11K 
                Investing LLC                                                    
 3: EX-99.23    Demand Promissory Note Payable to Rebecca Lazar     HTML     11K 
 4: EX-99.24    Consent of Independent Auditor                      HTML      5K 
 5: EX-99.25    Consent of Prior Independent Auditor                HTML      6K 
 6: EX-99.26    Michael Gillespie & Associates, Pllc No             HTML      6K 
                Disagreement Letter to the Securities and Exchange               
                Commission

‘EX-99.26’ — Michael Gillespie & Associates, Pllc No Disagreement Letter to the Securities and Exchange Commission

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 26

MICHAEL GILLESPIE & ASSOCIATES, PLLC

CERTIFIED PUBLIC ACCOUNTANTS

10544 ALTON AVE NE

SEATTLE, WA 98125

206.353.5736

November 18, 2020

Office of the Chief Accountant

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Re: Adorbs, Inc.

Dear Sirs/Madams:

The undersigned Michael Gillespie & Associates, PLLC previously acted as independent accountants of Adorbs, Inc. We are no longer acting as independent accountants to the Company.

This letter will confirm that we have read Item 14 included in the amended Form 10 dated November 18, 2020 of Adorbs, Inc. to be filed with the Securities and Exchange Commission and are in agreement with the statements related to our firm.

We hereby consent to the filing of this letter as an exhibit to the foregoing report on the amended Form 10.

Very truly,

/S/ MICHAEL GILLESPIE & ASSOCIATES, PLLC

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-12G/A’ Filing	Date	Other Filings

Filed on:	11/18/20	CORRESP
		List all Filings

14 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/20/23  Adorbs Inc.                       10-Q        9/30/23   41:2.4M                                   Empire Filings/FA
 9/27/23  Soul Biotechnology Corp.          10-Q        6/30/23   41:2.4M                                   Empire Filings/FA
 5/15/23  Soul Biotechnology Corp.          10-Q        3/31/23   38:2.2M                                   Empire Filings/FA
10/21/22  Soul Biotechnology Corp.          10-Q        9/30/22   38:2.4M                                   Empire Filings/FA
 8/01/22  Soul Biotechnology Corp.          10-Q        6/30/22   38:2.1M                                   Empire Filings/FA
 5/10/22  Soul Biotechnology Corp.          10-Q        3/31/22   38:1.8M                                   Empire Filings/FA
 2/08/22  Soul Biotechnology Corp.          10-K       12/31/21   29:1.4M                                   Empire Filings/FA
12/09/21  Soul Biotechnology Corp.          10-K/A     12/31/20   28:1M                                     Empire Filings/FA
10/13/21  Soul Biotechnology Corp.          10-Q        9/30/21   29:1.3M                                   Empire Filings/FA
 7/23/21  Soul Biotechnology Corp.          10-Q        6/30/21   29:1.3M                                   Empire Filings/FA
 5/03/21  Soul Biotechnology Corp.          10-Q        3/31/21   28:926K                                   EdgarAgents LLC/FA
 2/10/21  Soul Biotechnology Corp.          10-K       12/31/20   28:1.1M                                   EdgarAgents LLC/FA
12/22/20  Soul Biotechnology Corp.          10-12G/A               4:704K                                   EdgarAgents LLC/FA
12/14/20  Soul Biotechnology Corp.          10-12G/A               5:709K                                   EdgarAgents LLC/FA

1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/19/18  Soul Biotechnology Corp.          S-1                    6:1M                                     S2 Filings LLC/FA

↑Top

Filing Submission 0001213900-20-037931 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)